Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1157 |
|---|---|
| Identifier | NCT06260267 |
| Trial Title | A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Microbiota suspension|DRUG: Microbiota capsule|DRUG: Placebo suspension|DRUG: Placebo capsule |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | North Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2024-03-12 |
|---|---|
| Primary Completion Date | 2026-01-15 |
| Completion Date | 2026-01-15 |